tiprankstipranks
Entia Biosciences Inc (ERGO)
OTHER OTC:ERGO
US Market

Entia Biosciences (ERGO) Stock Price & Analysis

6 Followers

ERGO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.01
Previous Close$0.01
Volume6.00K
Average Volume (3M)N/A
Market Cap
$3.37K
Enterprise Value$973.50K
Total Cash (Recent Filing)$76.05K
Total Debt (Recent Filing)$1.05M
Price to Earnings (P/E)N/A
Beta0.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding33,660,947
10 Day Avg. Volume600
30 Day Avg. VolumeN/A
Standard Deviation9.57
R-Squared0.00491
Alpha1.29
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.67
Enterprise Value/Gross Profit5.60
Enterprise Value/Ebitda-0.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.00%0.30%99.70%
0.00%
Insiders
0.00%
Mutual Funds
0.30% Other Institutional Investors
99.70% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

ERGO FAQ

What was Entia Biosciences Inc’s price range in the past 12 months?
Entia Biosciences Inc lowest stock price was $0.00 and its highest was $0.01 in the past 12 months.
    What is Entia Biosciences Inc’s market cap?
    Currently, no data Available
    When is Entia Biosciences Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Entia Biosciences Inc’s earnings last quarter?
    Currently, no data Available
    Is Entia Biosciences Inc overvalued?
    According to Wall Street analysts Entia Biosciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Entia Biosciences Inc pay dividends?
      Entia Biosciences Inc does not currently pay dividends.
      What is Entia Biosciences Inc’s EPS estimate?
      Entia Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Entia Biosciences Inc have?
      Entia Biosciences Inc has 33,661,000 shares outstanding.
        What happened to Entia Biosciences Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Entia Biosciences Inc?
        Currently, no hedge funds are holding shares in ERGO
        ---

        Entia Biosciences Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Company Description

        Entia Biosciences Inc

        Entia Biosciences, Inc. operates as a biotechnology company. It is engaged in the discovery, formulation, production and marketing of functional ingredients that can be used in branded medical foods, nutraceuticals, cosmetics and other products. The company market nutraceutical products under the GROH and SANO brands direct to consumers online and through hair salons and other resellers in North America. Entia Biosciences was founded by Marvin S. Hausman on July 19, 2007 and is headquartered in Sherwood, OR.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Corbus Pharmaceuticals
        Eiger Biopharmaceuticals
        G1 Therapeutics
        Editas Medicine
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis